Skip to main content
  • ABBOTT ANNOUNCES EUROPEAN APPROVAL OF TWO LIFE-SAVING HEART DEVICES FOR BABIES AND CHILDREN

    ABBOTT PARK, Ill., Sept. 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP™ 15mm rotatable mechanical heart valve and the Amplatzer Piccolo™ Occluder have received CE Mark and are now available in Europe and other countries that recognize CE Mark. The new treatments, already available in the U.S., offer young pediatric patients and their families hope when no other suitable treatment option may exist. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details